- Home
- BCYC vs ORC Comparison
BCYC vs ORC Comparison
Compare BCYC & ORC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCYC
- ORC
- Stock Information
- Founded
- BCYC 2009
- ORC 2010
- Country
- BCYC United Kingdom
- ORC United States
- Employees
- BCYC N/A
- ORC N/A
- Industry
- BCYC Biotechnology: Pharmaceutical Preparations
- ORC Real Estate Investment Trusts
- Sector
- BCYC Health Care
- ORC Real Estate
- Exchange
- BCYC Nasdaq
- ORC Nasdaq
- Market Cap
- BCYC 566.5M
- ORC 660.1M
- IPO Year
- BCYC 2019
- ORC 2013
- Fundamental
- Price
- BCYC $8.22
- ORC $6.82
- Analyst Decision
- BCYC Buy
- ORC Buy
- Analyst Count
- BCYC 10
- ORC 4
- Target Price
- BCYC $25.00
- ORC $9.50
- AVG Volume (30 Days)
- BCYC 333.0K
- ORC 3.7M
- Earning Date
- BCYC 05-01-2025
- ORC 07-24-2025
- Dividend Yield
- BCYC N/A
- ORC 21.08%
- EPS Growth
- BCYC N/A
- ORC N/A
- EPS
- BCYC N/A
- ORC 0.46
- Revenue
- BCYC $25,722,000.00
- ORC $52,240,000.00
- Revenue This Year
- BCYC N/A
- ORC $46.17
- Revenue Next Year
- BCYC $1.83
- ORC $26.45
- P/E Ratio
- BCYC N/A
- ORC $14.89
- Revenue Growth
- BCYC N/A
- ORC N/A
- 52 Week Low
- BCYC $6.10
- ORC $5.69
- 52 Week High
- BCYC $28.67
- ORC $9.01
- Technical
- Relative Strength Index (RSI)
- BCYC 49.16
- ORC 39.47
- Support Level
- BCYC $8.00
- ORC $6.70
- Resistance Level
- BCYC $8.73
- ORC $7.11
- Average True Range (ATR)
- BCYC 0.48
- ORC 0.15
- MACD
- BCYC 0.02
- ORC -0.02
- Stochastic Oscillator
- BCYC 33.33
- ORC 20.25
About BCYC Bicycle Therapeutics plc
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.
About ORC Orchid Island Capital Inc.
Orchid Island Capital Inc is a specialty finance company that invests in residential mortgage-backed securities. The principal and interest payments of its RMBS are guaranteed by the Federal National Mortgage Association, the Federal Home Loan Mortgage Corporation, or the Government National Mortgage Association, and are backed by single-family residential mortgage loans. The company's investment portfolio is divided into two categories namely traditional pass-through Agency RMBS; and structured Agency RMBS, such as collateralized mortgage obligations, interest-only securities, inverse interest-only securities, and principal-only securities, among other types of structured Agency RMBS.